Cargando…
Dalbavancin in Real Life: Economic Impact of Prescription Timing in French Hospitals
INTRODUCTION: The extended half-life of dalbavancin justifies a once-a-week dosing schedule and is supposed to favour early discharge. These advantages may therefore compensate for the cost of dalbavancin, but no real-life assessment has been conducted to date. We aimed to assess the real-life budge...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847654/ https://www.ncbi.nlm.nih.gov/pubmed/34913137 http://dx.doi.org/10.1007/s40121-021-00577-6 |